Celebrating Women’s History Month: Meet Two of Memorial Hermann’s Longest-Tenured Female Employees

By Hannah Pietsch Memorial Hermann has 80 employees with more than 40 years of service, and 69 of these employees are women. As part of our celebration of Women’s History Month, we’re highlighting a few of the women at Memorial Hermann with the longest tenure. In 1971, Georgia Bertrand decided to apply for a job [Continue Reading]

Ali Vise

Ali Vise

Why I Chose to Get the COVID-19 Vaccine While Pregnant

By: Kristin Malaer During pregnancy and afterwards, mothers are faced with making tough decisions. Each has its own set of challenges, as every pregnancy is unique, and this is certainly the case with being pregnant during the COVID-19 pandemic. As a first-time mom, I was faced with decisions about how much to share, who to [Continue Reading]

Ali Vise

Celebrating Black History Month: Spotlight on Dr. Gary Sheppard

By Alexandra Becker As early as the seventh grade, Dr. Gary Sheppard knew he wanted to become a physician. He’d always enjoyed science, and the idea of helping people at the same time appealed to him. There were no doctors in his family and no life-altering events that shaped this decision: he simply knew it [Continue Reading]

Ali Vise

#Shot of Hope: Debbie’s Story

By Jade Waddy On Dec. 15, Memorial Hermann received its first shipment of the Pfizer COVID-19 vaccine. To date, the system has vaccinated tens of thousands of employees and members of the community following the State’s guidance for COVID-19 vaccine distribution, which prioritizes vaccination in its Phase 1A and Phase 1B. The COVID-19 pandemic has [Continue Reading]

Ali Vise

Monoclonal Antibodies a Promising Treatment in the Fight against COVID-19

By Alexandra Becker Late last year, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization for a drug called bamlanivimab, which harnesses monoclonal antibodies to fight the SARS-CoV-2 virus, which causes COVID-19 disease. Monoclonal antibodies are lab-made proteins designed to mimic the immune system’s production of natural antibodies. Bamlanivimab, which was shown [Continue Reading]

Ali Vise